SCHEMBL15906218

SCHEMBL15906218

CN(C)CC(C)(C)C(=O)N[C@H]1CC[C@H](C)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.43
ALDH1A1 P00352 4/20 0.43
POLB P06746 1/20 0.43
RECQL P46063 1/20 0.43
ADRA2A P08913 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
MAPK1 P28482 1/20 0.36
PKM P14618 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
GAA P10253 1/20 0.35
SSTR4 P31391 1/20 0.35
TAS1R3 Q7RTX0 2/20 0.34
TAS1R1 Q7RTX1 2/20 0.34
TAS1R2 Q8TE23 2/20 0.34
CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15906237 0.83 ALDH1A1 (0.42) EPHX1ALDH1A1POLBRECQLADRA2A
SCHEMBL14652177 0.83 PKM (0.37) EPHX1ALDH1A1PKMPDK1PDK2
SCHEMBL15906245 0.81 EPHX1 (0.47) EPHX1ALDH1A1POLBRECQLADRA2A
SCHEMBL14655013 0.79 EPHX1 (0.46) EPHX1ALDH1A1POLBRECQLADRA2A
SCHEMBL15906238 0.79 EPHX1 (0.46) EPHX1ALDH1A1POLBRECQLADRA2A
SCHEMBL14654940 0.78 EPHX1 (0.44) EPHX1ALDH1A1POLBRECQLADRA2A
SCHEMBL803835 0.78 EPHX1 (0.44) EPHX1ALDH1A1ADRA2ASMN1; SMN2NPC1
SCHEMBL13246733 0.76 EPHX1 (0.53) EPHX1ALDH1A1ADRA2ASMN1; SMN2NPC1
SCHEMBL26140573 0.76 EPHX1 (0.53) EPHX1ALDH1A1ADRA2ASMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL29904533 0.74 EPHX1 (0.52) EPHX1ALDH1A1ADRA2ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791257-B2 Substituted pyrrolotriazines as protein kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-07-29 US disclosed